• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

O-006 Influence of geolocational factors on patient outcomes post EVT: a population based analysis of transport over long distances in the province of Saskatchewan
ConclusionsReal world geographic factors influence time to treatment, however patient specific factors play a great role in determining patient’s overall outcome during long transports. Factors such as collaterals, occlusion location, and initial aspects are more important than number of kilometers distance travelled or transfer from PSC alone. In an efficient transport system, centralized treatment at the CSC is a viable solution and does not preclude achieving functionally independent outcomes.Abstract O-006 Figure 1Disclosures N. Kashani: None. A. Zhou: None. J. Ospel: None. N. Singh: None. A. Gardner: None. A. Pe...
Source: Journal of NeuroInterventional Surgery - July 30, 2023 Category: Neurosurgery Authors: Kashani, N., Zhou, A., Ospel, J., Singh, N., Gardner, A., Persad, A., Otani, R., Ahmed, U., Peeling, L., Kelly, M. Tags: SNIS 20th annual meeting oral abstracts Source Type: research

Three-month functional outcomes following endovascular thrombectomy during the first wave of the COVID-19 pandemic: a Canadian single-center cohort study
Conclusion In this single-center cohort study conducted in a Canadian pandemic epicenter, the first 6 months of the COVID-19 pandemic did not impact 90-day functional outcomes or death among EVT-treated patients.
Source: Journal of NeuroInterventional Surgery - February 16, 2022 Category: Neurosurgery Authors: Neves Briard, J., Dufort, G., Jacquin, G., Alesefir, W., Bereznyakova, O., Boisseau, W., Daneault, N., Deschaintre, Y., Diestro, J. D. B., Ducroux, C., Eneling, J., Gioia, L., Iancu, D. E., Odier, C., Raymond, J., Roy, D., Stapf, C., Weill, A., Poppe, A. Tags: COVID-19 The pandemic and neurointervention Source Type: research

E-011 Factors influencing thrombectomy decision-making for primary medium vessel occlusion stroke
ConclusionsMost physicians in this survey would treat MeVO stroke patients immediately with EVT, supporting the need for more robust clinical evidence.Disclosures P. Cimflova: None. M. Kappelhof: None. N. Singh: None. N. Kashani: None. J. Ospel: None. R. McDonough: None. A. Demchuk: None. B. Menon: None. N. Sakai: None. M. Chen: 2; C; Medtronic, Genentech, Stryker, Microvention, Cerenovus, Penumbra. J. Fiehler: 1; C; Acandis, Medtronic, Microvention, Stryker. 2; C; Acandis, Codman, Cerenovus, Microvention, Medtronic, Penumbra, Phenox, Stryker. M. Goyal: 2; C; Medtronic, Microvention, Stryker, GE Healthcare, Mentice.
Source: Journal of NeuroInterventional Surgery - July 26, 2021 Category: Neurosurgery Authors: Cimflova, P., Kappelhof, M., Singh, N., Kashani, N., Ospel, J., McDonough, R., Demchuk, A., Menon, B., Sakai, N., Chen, M., Fiehler, J., Goyal, M. Tags: Electronic poster abstracts Source Type: research

E-034 EndoVascular treatment of wide-neck aneurysms, an evaluation of safety and effectiveness of stryker surpass evolve™ flow diverter system
ConclusionThe EVOLVE prospective, multicenter, single arm, pre-market study (ClinicalTrials.gov NCT: NCT04195568), is designed to evaluate the safety, efficacy, and performance of the Surpass EVOLVE Flow Diverter System in the treatment of unruptured wide-neck, saccular or fusiform IA located in the ICA and its branches with an RVD of 2.5 to 5.0 mm.Disclosures A. Arthur: 2; C; Stryker Neurovascular. J. Fifi: 1; C; Stryker Neurovascular. 2; C; Stryker Neurovascular. H. Rice: 2; C; Stryker Neurovascular. A. Wakhloo: 2; C; Stryker Neurovascular. A. Coon: 2; C; Stryker Neurovascular. V. Pereira: 2; C; Stryker, Medtronic, Balt, Cerenovus.
Source: Journal of NeuroInterventional Surgery - July 26, 2021 Category: Neurosurgery Authors: Arthur, A., Fifi, J., Rice, H., Wakhloo, A., Coon, A., Pereira, V. Tags: Electronic poster abstracts Source Type: research